Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Cancers Originate from Somatic Mutations in a Single Cell02:21

Cancers Originate from Somatic Mutations in a Single Cell

Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Dynamic transitioning between MAPK-driven and WNT-driven cell states drives intestinal cancer and shapes therapy response.

Nature genetics·2026
Same author

Targeting NRF2 addiction in cancer: synthetic lethal strategies beyond direct inhibition.

Frontiers in cell and developmental biology·2026
Same author

Site-specific combinatorial ubiquitination drives the targeted degradation of plasma membrane proteins.

bioRxiv : the preprint server for biology·2026
Same author

A high-MAPK, low-WNT cell state drives metastatic dissemination in colorectal cancer.

Nature cancer·2026
Same author

A little longer, a lot better: simulation-guided exploration of extended-length single-end barcoded reads for structural variant detection.

bioRxiv : the preprint server for biology·2026
Same author

Loss of UXS1 Selectively Depletes Pyrimidines and Induces Replication Stress in KEAP1-Mutant Lung Cancer.

Cancer research·2025

相关实验视频

Updated: Jun 10, 2026

Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

在人类癌症中,各种体质突变模式和途径改变.

Zhengyan Kan1, Bijay S Jaiswal, Jeremy Stinson

  • 1Department of Molecular Biology, Genentech Inc., 1 DNA Way, South San Francisco, California 94080, USA.

Nature
|July 30, 2010
PubMed
概括

这项研究在441种癌症瘤中发现了1,507个基因中的2,576个体质突变. 关键的突变基因,包括GNAS和MAP2K4,为新型癌症疗法提供了潜在的目标.

更多相关视频

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
11:02

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing

Published on: October 18, 2013

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

相关实验视频

Last Updated: Jun 10, 2026

Comparative Lesions Analysis Through a Targeted Sequencing Approach
08:16

Comparative Lesions Analysis Through a Targeted Sequencing Approach

Published on: November 5, 2019

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing
11:02

Detecting Somatic Genetic Alterations in Tumor Specimens by Exon Capture and Massively Parallel Sequencing

Published on: October 18, 2013

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

科学领域:

  • 基因组学就是基因组学.
  • 癌症生物学 癌症生物学
  • 分子瘤学分子瘤学

背景情况:

  • 癌症基因组中的体质突变对于了解疾病机制至关重要.
  • 开发向疗法需要全面的基因组表征.

研究的目的:

  • 系统地识别和描述主要人类癌症类型的体质突变.
  • 为了发现癌症治疗的新型可用药物点.

主要方法:

  • 441个瘤 (乳腺,肺,卵巢,前列腺) 的全基因组测序.
  • 实体突变和副本数量变化的识别和统计分析.
  • 关键突变基因 (GNAO1,MAP2K4) 的功能研究.

主要成果:

  • 在1,507个编码基因中发现了2,576个体质突变.
  • 在瘤类型/亚型中发现突变率和基因组的显著变化.
  • 发现了77个显著突变的基因 (例如GRM8,BAI3,AGTRL1,LPHN3) 和35个额外的改变基因 (例如GNAS).
  • 突变GNAO1和MAP2K4在瘤发生过程中的功能性作用.

结论:

  • 人类癌症的突变格局是多样化的,并且特定于亚型.
  • 确定了许多潜在的治疗点,包括G蛋白结合受体和信号通路组件.
  • 突出了G-α子单元在癌症发展中的扩大作用.